Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study

Summary Within the Campus ALL network we analyzed the incidence, characteristics, treatment and outcome of a central nervous system (CNS) relapse in 1035 consecutive adult acute lymphoblastic leukemia (ALL) patients treated frontline with pediatric‐inspired protocols between 2009 and 2020. Seventy‐o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2023-02, Vol.200 (4), p.440-450
Hauptverfasser: Dargenio, Michelina, Bonifacio, Massimiliano, Chiaretti, Sabina, Vitale, Antonella, Fracchiolla, Nicola Stefano, Papayannidis, Cristina, Giglio, Fabio, Salutari, Prassede, Audisio, Ernesta, Scappini, Barbara, Zappasodi, Patrizia, Defina, Marzia, Forghieri, Fabio, Scattolin, Anna Maria, Todisco, Elisabetta, Lunghi, Monia, Guolo, Fabio, Del Principe, Maria Ilaria, Annunziata, Mario, Lazzarotto, Davide, Cedrone, Michele, Pasciolla, Crescenza, Imovilli, Annalisa, Tanasi, Ilaria, Trappolini, Silvia, Cerrano, Marco, La Starza, Roberta, Krampera, Mauro, Di Renzo, Nicola, Candoni, Anna, Pizzolo, Giovanni, Ferrara, Felicetto, Foà, Robin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Within the Campus ALL network we analyzed the incidence, characteristics, treatment and outcome of a central nervous system (CNS) relapse in 1035 consecutive adult acute lymphoblastic leukemia (ALL) patients treated frontline with pediatric‐inspired protocols between 2009 and 2020. Seventy‐one patients (6.8%) experienced a CNS recurrence, more frequently in T‐ (28/278; 10%) than in B‐ALL (43/757; 5.7%) (p = 0.017). An early CNS relapse—< 12 months from diagnosis—was observed in 41 patients. In multivariate analysis, risk factors for early CNS relapse included T‐cell phenotype (p = 100 × 109/L (p
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.18537